ANDREWS DEBORAH J 4

Accession 0001209191-20-004627

CIK 0000718937other

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:06 PM ET

Size

40.7 KB

Accession

0001209191-20-004627

Insider Transaction Report

Form 4

Period: 2020-01-21

STAAR SURGICAL COSTAA

ANDREWS DEBORAH J

VP & Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock Options
2020-01-21−10,000→ 0 total
Exercise: $15.54Exp: 2024-03-06→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock Options
2020-01-21−7,291→ 347 total
Exercise: $16.15Exp: 2028-03-14→ Common Stock (7,291 underlying)
Exercise/Conversion
Common Stock
2020-01-21$11.00/sh+20,000$220,000→ 52,101 total
Exercise/Conversion
Common Stock
2020-01-21$7.35/sh+15,000$110,250→ 97,101 total
Exercise/Conversion
Common Stock
2020-01-21$7.36/sh+9,000$66,240→ 106,101 total
Exercise/Conversion
Common Stock
2020-01-21$15.25/sh+17,360$264,740→ 128,044 total
Exercise/Conversion
Common Stock Options
2020-01-21−20,000→ 0 total
Exercise: $5.34Exp: 2023-03-03→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock Options
2020-01-21−17,360→ 695 total
Exercise: $15.25Exp: 2027-11-12→ Common Stock (17,360 underlying)
Exercise/Conversion
Common Stock Options
2020-01-21−3,370→ 188 total
Exercise: $29.80Exp: 2021-06-13→ Common Stock (3,370 underlying)
Exercise/Conversion
Common Stock
2020-01-21$5.34/sh+20,000$106,800→ 72,101 total
Exercise/Conversion
Common Stock
2020-01-21$15.54/sh+10,000$155,400→ 82,101 total
Exercise/Conversion
Common Stock
2020-01-21$9.30/sh+4,583$42,622→ 110,684 total
Exercise/Conversion
Common Stock
2020-01-21$16.15/sh+7,291$117,750→ 135,335 total
Sale
Common Stock
2020-01-21$42.20/sh−106,604$4,498,689→ 32,101 total
Exercise/Conversion
Common Stock
2020-01-21$29.80/sh+3,370$100,426→ 138,705 total
Exercise/Conversion
Common Stock Options
2020-01-21−20,000→ 0 total
Exercise: $11.00Exp: 2022-03-01→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock Options
2020-01-21−15,000→ 0 total
Exercise: $7.35Exp: 2025-04-06→ Common Stock (15,000 underlying)
Exercise/Conversion
Common Stock Options
2020-01-21−9,000→ 0 total
Exercise: $7.36Exp: 2026-04-03→ Common Stock (9,000 underlying)
Exercise/Conversion
Common Stock Options
2020-01-21−4,583→ 139 total
Exercise: $9.30Exp: 2027-03-20→ Common Stock (4,583 underlying)

Footnotes (10)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.86 to $42.53, inclusive.
[F10]The options granted become exercisable as follows: 1/3 on 06/14/2019, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 06/14/2021.
[F2]These stock options became exercisable in three equal annual installments on March 4, 2014, March 4, 2015, and March 4, 2016.
[F3]These stock options became exercisable in three equal annual installments on March 2, 2013, March 2, 2014, and March 2, 2015.
[F4]These stock options became exercisable in three equal annual installments on March 7, 2015, March 7, 2016, and March 7, 2017.
[F5]These stock options became exercisable in three equal annual installments on April 7, 2016, April 7, 2017, and April 7, 2018.
[F6]The options granted became exercisable as follows: 1/3 on 04/04/2017, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted became exercisable on 04/04/2019.
[F7]The options granted become exercisable as follows: 1/3 on 03/21/2018, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 03/21/2020.
[F8]The options granted become exercisable as follows: 1/3 on 11/13/2018, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 11/13/2020.
[F9]The options granted become exercisable as follows: 1/3 on 03/15/2019, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 03/15/2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

STAAR SURGICAL CO

CIK 0000718937

→

Entity typeother

Related Parties

filerCIK 0001325697

Filing Metadata

Form type: 4
Filed: Jan 22, 7:00 PM ET
Accepted: Jan 23, 4:06 PM ET
Size: 40.7 KB

View on SEC.gov